Antibody therapy for rheumatoid arthritis.
High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...
Главный автор: | Taylor, P |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2003
|
Схожие документы
-
Humanised monoclonal antibody therapy for rheumatoid arthritis.
по: Isaacs, J, и др.
Опубликовано: (1992) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
по: Isaacs, J, и др.
Опубликовано: (1992) -
Anti-cytokine therapy for rheumatoid arthritis.
по: Maini, R, и др.
Опубликовано: (2000) -
Anti-TNFalpha therapy for rheumatoid arthritis: an update.
по: Taylor, P
Опубликовано: (2003) -
Antikeratin antibodies in rheumatoid arthritis
по: J Zabek
Опубликовано: (2003-02-01)